HIV-negative children’s experiences and opinions towards parental HIV disclosure: a qualitative study in China

In HIV/AIDS research, few studies to date have evaluated ways to improve parental HIV disclosure practices using feedback from HIV-negative children who have recently experienced this event. We conducted semi-structured in-depth interviews with 20 children (aged 6–15) who were partially to fully aware of their parents’ HIV status in rural Guangxi, China. Of the 20 children, eight children who were of older age (11.38 years in average) endorsed parental HIV disclosure, five discouraged it and seven expressed uncertainty. Children’s different experiences and attitudes towards disclosure were seen to be associated with their family dynamics (especially the parent–child relationship), social support and care, experiences of stigma and discrimination, psychosocial suffering, comprehension of the disease and the children’s age. Our study contributes to building a child-centered comprehensive understanding for Chinese parental HIV disclosure. It is imperative that counselors and community advocates assess and help parents achieve optimal readiness preceding disclosure of their illness to their HIV-negative children.     

Chalcone hybrids and their antimalarial activity

Malaria, one of the most striking, re-emerging infectious diseases caused by the genus Plasmodium, places a huge burden on global healthcare systems. A major challenge in the control and eradication of malaria is the continuous emergence of increasingly widespread drug-resistant malaria, creating an urgent need to develop novel antimalarial agents. Chalcone derivatives are ubiquitous in nature and have become indispensable units in medicinal chemistry applications due to their diverse biological profiles. Many chalcone derivatives demonstrate potential in vitro and in vivo antimalarial activity, so chalcone could be a useful template for the development of novel antimalarial agents. This review covers the recent development of chalcone hybrids as antimalarial agents. The critical aspects of the design and structure–activity relationship of these compounds are also discussed.     

Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy

Chronic hepatitis C virus (HCV) infection represents a major health threat to global population. In India, approximately 15–20% of cases of chronic liver diseases are caused by HCV infection. Although, new drug treatments hold great promise for HCV eradication in infected individuals, the treatments are highly expensive. A vaccine for preventing or treating HCV infection would be of great value, particularly in developing countries. Several preclinical trials of virus-like particle (VLP) based vaccine strategies are in progress throughout the world. Previously, using baculovirus based system, we have reported the production of hepatitis C virus-like particles (HCV-LPs) encoding structural proteins for genotype 3a, which is prevalent in India. In the present study, we have generated HCV-LPs using adenovirus based system and tried different immunization strategies by using combinations of both kinds of HCV-LPs with other genotype 3a-based immunogens. HCV-LPs and peptides based ELISAs were used to evaluate antibody responses generated by these combinations. Cell-mediated immune responses were measured by using T-cell proliferation assay and intracellular cytokine staining. We observed that administration of recombinant adenoviruses expressing HCV structural proteins as final booster enhances both antibody as well as T-cell responses. Additionally, reduction of binding of VLP and JFH1 virus to human hepatocellular carcinoma cells demonstrated the presence of neutralizing antibodies in immunized sera. Taken together, our results suggest that the combined regimen of VLP followed by recombinant adenovirus could more effectively inhibit HCV infection, endorsing the novel vaccine strategy.     

Characterization of two pigeon paramyxovirus type 1 isolates in China

For over three decades, there has been a continuing panzootic caused by a virulent variant avian paramyxovirus type 1 strain, the so-called pigeon paramyxovirus type 1. It is found primarily in racing pigeons, but it has also spread to wild birds and poultry. In this study, two pigeon paramyxovirus type 1 strains, SD12 and BJ13, obtained from diseased pigeons in China, were characterized. Phylogenetic analysis based on complete sequences allowed characterization of both strains as genotype VI, class II. Further phylogenetic analysis of a 374-nucleotide section of the fusion gene showed that SD12 fell into lineage VIbii-d and BJ13 into VIbii-f. The deduced amino acid sequence of the cleavage site of the fusion protein confirmed that both isolates contained the virulent motif ¹¹²K/RRQKR↓F¹¹⁷ at the cleavage site. Nevertheless, the values of intracerebral pathogenicity indices showed the SD12 isolate to be a velogenic strain and BJ13 isolate to be a mesogenic strain. The SD12 isolate was further investigated via clinical observation, RNA detection, histopathology and viral serology in experimentally infected 3-week-old chickens. It showed a mild pathological phenotype in chickens, with viral replication restricted to a few tissues. The molecular mechanism for the SD12 isolate to have a virulent motif but low levels of virulence for chickens requires further study.     

2016年4月—2022年3月深圳市和济南市流感病原学监测及流行特征

目的 分析在新型冠状病毒肺炎流行背景下,2016年4月—2022年3月国内深圳市和济南市流感流行特点,了解我国南北方地区流感流行差异。 方法 使用深圳市和济南市国家级哨点医院2016—2022监测年度流感样病例(ILI)和流感病原学监测资料,分析流感流行特征和趋势。 结果 2016—2022监测年度深圳市和济南市国家级哨点医院的门急诊病例中流感样病例百分比(ILI%)分别为2.25%、3.45%。两地区ILI%最高的年份均为2021—2022监测年度。ILl年龄构成均以0~4岁为主(分别占40%、46%)。按月分析两地区流感病毒分离阳性率与ILI%变化的相关性,两者趋势均存在正相关(r=0.238,P<0.05;r=0.425,P<0.001)。两地区不同监测年度流感优势毒株型别均不相同,呈交替变化,但每年流行的型别及高峰期的优势毒株型别基本一致。 结论 2020—2021监测年度即新型冠状病毒肺炎流行初期,深圳市和济南市流感活跃程度明显低于往年平均水平且流行毒株型别单一,其余监测年度基本符合我国南、北方地区流感流行特征。     

山东省发热伴血小板减少综合征发病危险因素分析

目的 探讨影响山东省发热伴血小板减少综合征（SFTS）发病的危险因素,为科学防制该病提供依据。方法 应用1∶2匹配的病例对照研究方法,调查收集病例、对照的基本情况、可疑暴露因素等信息,采用单因素和多因素的配对条件logistic回归分析发病危险因素。结果 本研究共纳入374例SFTS确诊病例和748例对照。分析结果显示,有病例接触史（OR = 5.84,95%CI:1.11～30.88）、有家养动物（OR = 1.74,95%CI: 1.02～2.96）、近1个月见过蜱（OR = 5.85,95%CI: 2.73～12.53）、近2周有蜱叮咬史（OR = 29.58,95%CI: 6.70～130.60）、从事田间作业（OR = 2.63,95%CI:1.41～4.91）、住宅周围环境有杂草/农作物/菜地（OR = 3.24,95%CI:1.74～6.05）和住宅卫生条件差（OR = 2.20,95%CI:1.32～3.66）是SFTS发病的危险因素（P＜0.05）,近1个月有亲邻发病（OR = 0.01,95%CI:0～0.03）、采取防护措施（OR = 0.21,95%CI:0.10～0.46）是SFTS发病的保护因素（P＜0.05）。结论 接触病例、饲养家养动物、蜱叮咬、无防护措施的野外作业及住宅周围环境卫生较差等是影响山东省SFTS发病的危险因素。应加强重点人群SFTS健康教育和行为干预,减少危险因素暴露,以控制SFTS传播。     

一起由磷化铝引起的家庭聚集性中毒事件的调查分析

目的 分析一起由磷化铝引起的家庭聚集性中毒事件的流行病学特征,为今后处置类似事件提供科学的依据。方法 对2021年济南市商河县一起急性中毒事件开展现场流行病学调查和实验室检测。调查主要针对病例及其家属进行面访,并入户考察和采集食品、环境标本和病例标本。结果 本事件共涉及7人,其中病例6例,罹患率85.7%,病例男女比例1∶1.33（3∶4）,1例死亡。指示病例发病时间为23日20时左右,末例发病时间为24日6时左右,推测潜伏期为8～12小时。临床表现以呕吐（100%）、阵发性腹痛（100%）、恶心（43%）和腹泻（43%）为主。未发现家庭成员有可疑共同暴露餐次和可疑暴露食品。实验室在所采集的环境空气样本和死亡病例的血中检出磷化氢（PH3）。结论 本次事件是一起磷化铝使用不当引起的家庭聚集性磷化铝中毒事件,储粮间的磷化铝吸潮挥发产生的磷化氢是主要致病因素。     

2016—2020年菏泽市食源性疾病暴发动态分析与防治对策

目的 对菏泽市食源性疾病暴发进行动态分析,为有效预防食源性疾病的发生提供有效的防治对策。方法 采用Excel及SPSS 16.0统计软件对2016年—2020年菏泽市5年食源性疾病暴发情况进行描述统计分析。结果 2016—2020年菏泽市食源性疾病暴发事件年平均罹患率分别是14.71%,25.59%,18.33%,34.34%,5.34%。该五年的年平均罹患率17.14%之间差异有统计学意义(χ2=375.10,P＜0.001);年份作为有序变量资料进行秩和检验(Z=-8.95,P＜0.001)。菏泽市食源性疾病暴发以7—9月份暴发起数最多,暴发起数128起(占比51.20%),植物类食品在报告起数方面(73起)及罹患率方面(80.00%)均较高;污染物类别方面,不同污染物类别平均罹患率间差异有统计学意义(χ2=132.70,P＜0.001),致病微生物及毒素、化学污染物所占构成比较高;引起食源性疾病暴发的主要原因是食品加工储存不当,误食误用等;不同发生场所平均罹患率间差异有统计学意义χ2=243.70,P＜0.001),家庭、宾馆饭店、街头摊点是高发场所。结论 政府及卫生行政部门应针对家庭、宾馆饭店、街头摊点重点场所,尽可能查明食源性疾病暴发的原因,各部门应加强配合、监管及宣传。     

聊城市5起新型冠状病毒肺炎聚集性疫情流行病学分析

目的 分析新型冠状病毒肺炎(简称新冠肺炎)聚集性疫情的流行病学特征,为制定疫情防控策略和措施提供科学依据。 方法 于2020年1月24日—2月11日在聊城市应用现场流行病学方法调查5起新冠肺炎聚集性疫情所涉及的41例确诊病例及无症状感染者, 对相关标本采用实时荧光定量RT-PCR方法进行核酸检测。 结果 5起聚集性疫情的首发病例续发率为2.78%~50.00%,差异有统计学意义(χ²=21.57,P<0.01);家庭聚集性疫情涉及32例、10户家庭(族),公共场所聚集性疫情涉及16例、2个场所。一、二、三代病例分别有5、22、12例,传染率分别为100.00%、18.18%、0.00%。4例病例的潜伏期为5~10 d,中位数为7.5 d;聚集性疫情中存在潜伏期传播。有疫区旅行史或居住史者4例(9.76%),与潜伏期病例或确诊病例有密切接触、频繁交谈等有30例(73.17%),暴露于高浓度气溶胶4例(9.76%),未知感染来源3例(7.32%)。 结论 新冠病毒极易引起聚集性疫情,控制本地的聚集性疫情是防控工作的重点;新冠病毒可以通过高浓度气溶胶传播;病例在潜伏期具有感染性。